Skip to main content
Log in

Morbidity of subtotal colectomy in patients with severe ulcerative colitis unresponsive to cyclosporin

  • Original Contributions
  • Published:
Diseases of the Colon & Rectum

Abstract

PURPOSE: The aim of this study was to document the morbidity of urgent subtotal colectomy and ileostomy in patients with severe ulcerative colitis who failed cyclosporin treatment. METHODS: We reviewed the charts of patients with severe ulcerative colitis who did not respond to cyclosporin treatment and underwent urgent subtotal colectomy and Brooke ileostomy at two inflammatory bowel disease centers over the 12-month period ending April 1994. RESULTS: Fourteen patients (6 males; mean age, 34 years) required an urgent subtotal colectomy and Brooke ileostomy after failing treatment with cyclosporin. There were no deaths. Eight patients (57 percent) developed postoperative complications, which included ileus (3), deep vein thrombosis (2), wound infection (2), and partial dehiscence of rectal stump (1). Mean length of postoperative hospital stay was 8.8 days. CONCLUSIONS: These initial data suggest that cyclosporin treatment may not influence the safety of urgent surgical treatment in severe ulcerative colitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Targan SR, Kagnoff MF, Brogan MD, Shanahan F. Immunologic mechanisms in intestinal diseases. Ann Intern Med 1987;106:853–70.

    PubMed  CAS  Google Scholar 

  2. Lichtiger S, Present DH. Preliminary report: cyclosporin in treatment of severe active ulcerative colitis. Lancet 1990;336:16–9.

    Article  PubMed  CAS  Google Scholar 

  3. Sandborn WJ, Tremaine WJ. Cyclosporine treatment of inflammatory bowel disease. Mayo Clin Proc 1992;67:981–90.

    PubMed  CAS  Google Scholar 

  4. Prokupek DA, Kashyap PK, Targan SR, Plevy SE, Choi PM. Cyclosporin in the treatment of refractory UC: determinants of a successful outcome at 6 months [abstract]. Gastroenterology 1994;106:756.

    Google Scholar 

  5. Lichtiger S, Present DH, Kornbluth A, Michelassi F, Hanauer SB. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330:1841–5.

    Article  PubMed  CAS  Google Scholar 

  6. Ptachcinski RJ, Venkataramanan R, Burckart GJ. Clinical pharmacokinetics of cyclosporin. Clin Pharmacokinet 1986;11:107–32.

    Article  PubMed  CAS  Google Scholar 

  7. Bunjes D, Hardt C, Rollinghoff M, Wagner H. Cyclosporin A mediates immunosuppression of primary cyto-toxic T-cell responses by impairing the release of interleukin-1 and interleukin-2. Eur J Immunol 1981;11:657–61.

    PubMed  CAS  Google Scholar 

  8. Elliott JF, Lin Y, Mizel SB,et al. Induction of interleukin 2 messenger RNA inhibited by cyclosporin A. Science 1984;226:1439–41.

    PubMed  CAS  Google Scholar 

  9. Kupiec-Welglinski JW, Filho MA, Strom TB, Tilney NL. Sparing of suppressor cells: a critical action of cyclosporine. Transplantation 1984;38:97–101.

    PubMed  Google Scholar 

  10. Reed JC, Prystowsky MB, Nowell PC. Regulation of gene expression in lectin-stimulated or lymphokine-stimulated T lymphocytes. Transplantation 1991;4(Suppl):85S-89S.

    Google Scholar 

  11. Brynskov J, Tvede N. Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease: effect of cyclosporine. Gut 1990;31:795–9.

    PubMed  CAS  Google Scholar 

  12. Brynskov J, Tvede N, Andersen CB, Vilien M. Increased concentrations of interleukin-1B, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. Gut 1992;33:55–8.

    PubMed  CAS  Google Scholar 

  13. MacDermott RP, Nash GS, Auer IO,et al. Alterations in serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease. Gastroenterology 1989;96:764–8.

    PubMed  CAS  Google Scholar 

  14. Kett K, Rognum TO, Brandtzaeg P. Mucosal subclass distribution of immunoglobulin G-producing cells is different in ulcerative colitis and Crohn's disease of the colon. Gastroenterology 1987;93:919–24.

    PubMed  CAS  Google Scholar 

  15. Kolars JC, Awni WM, Merion RM, Watkins PB. First-pass metabolism of cyclosporin by the gut. Lancet 1991;338:1488–90.

    Article  PubMed  CAS  Google Scholar 

  16. Cockburn I. Assessment of the risks of malignancy and lymphomas developing in patients using Sandimmune. Transplant Proc 1987;19:1804–7.

    PubMed  CAS  Google Scholar 

  17. Albrechtsen D, Bergan A, Gjone E, Nygaard K, Flatmark A. Elective surgery for ulcerative colitis:colectomy in 158 patients. Scand J Gastroenterol 1981;16:825–31.

    Article  PubMed  CAS  Google Scholar 

  18. Johnson WR, Hughes ES, McDermott FT, Pihl EA, Katrivessis H. The outcome of patients with ulcerative colitis managed by subtotal colectomy. Surg Gynecol Obstet 1986;162:421–5.

    PubMed  CAS  Google Scholar 

  19. Adams DH, Wang LF, Neuberger JM, Elias E. Inhibition of leukocyte chemotaxis by immunosuppressive agents. Transplantation 1990;50:845–50.

    Article  PubMed  CAS  Google Scholar 

  20. Fishel R, Barbul A, Wasserkrug HL, Penberthy LT, Rettura G, Efron G. Cyclosporine A impairs wound healing in rats. J Surg Res 1983;34:572–5.

    Article  PubMed  CAS  Google Scholar 

  21. Vanrenterghem Y, Lerut T, Roels L,et al. Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients. Lancet 1985;1:999–1002.

    Article  PubMed  CAS  Google Scholar 

  22. Dummer JS, Hardy A, Poorsattar A, Ho M. Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation 1983;36:259–67.

    PubMed  CAS  Google Scholar 

  23. Ritchie JK. Ulcerative colitis treated by ileostomy and excisional surgery. Br J Surg 1972;59:345–51.

    PubMed  CAS  Google Scholar 

  24. Binder SC, Miller HH, Deterling RA Jr. Emergency and urgent operations for ulcerative colitis. Arch Surg 1975;110:284–9.

    PubMed  CAS  Google Scholar 

  25. Albrechtsen D, Bergan A, Nygaard K, Gjone E, Flatmark A. Urgent surgery for ulcerative colitis: early colectomy in 132 patients. World J Surg 1981;5:607–15.

    Article  PubMed  CAS  Google Scholar 

  26. Carter FM, McLeod RS, Cohen Z. Subtotal colectomy for ulcerative colitis: complications related to the rectal remnant. Dis Colon Rectum 1991;34:1005–9.

    Article  PubMed  CAS  Google Scholar 

  27. Kyle SM, Steyn RS, Keenan RA. Management of the rectum following colectomy for acute colitis. Aust N Z J Surg 1992;62:196–9.

    PubMed  CAS  Google Scholar 

  28. Ng RL, Davies AH, Grace RH, Mortensen NJ. Subcutaneous rectal stump closure after emergency subtotal colectomy. Br J Surg 1992;79:701–3.

    PubMed  CAS  Google Scholar 

  29. Penna C, Daude F, Parc R,et al. Previous subtotal colectomy with ileostomy and sigmoidostomy improves the morbidity and early functional results after ileal pouch-anal anastomosis in ulcerative colitis. Dis Colon Rectum 1993;36:343–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Fleshner, P.R., Michelassi, F., Rubin, M. et al. Morbidity of subtotal colectomy in patients with severe ulcerative colitis unresponsive to cyclosporin. Dis Colon Rectum 38, 1241–1245 (1995). https://doi.org/10.1007/BF02049146

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02049146

Key words

Navigation